Biopharmaceuticals Contract Manufacturing Market Size Forecast: Revenue and CAGR by 2029

November 13, 2025 by The Business Research Company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Biopharmaceuticals Contract Manufacturing Industry By The Forecast Year 2029?

The biopharmaceuticals contract manufacturing market has experienced substantial expansion in recent years. Its valuation is projected to increase from $20.13 billion in 2024 to $22.22 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.4%. Historically, this expansion has been driven by several factors, including heightened biopharmaceutical development, improved cost efficiency and risk mitigation strategies, a burgeoning pipeline of biologics, the globalization of the biopharmaceutical sector, and the availability of adaptable manufacturing solutions.

The biopharmaceuticals contract manufacturing market is projected to experience swift expansion in the coming years. By 2029, its value is anticipated to reach $33.99 billion, demonstrating an 11.2% compound annual growth rate (CAGR). This expansion during the projection period stems from factors such as a rise in outsourcing, advances in biosimilar creation, demands for quicker market entry, worldwide market enlargement, and an emphasis on specific services. Key developments expected over this timeframe encompass the integration of technology, the extension of outsourcing beyond large molecules, the adoption of sophisticated manufacturing techniques, a strong focus on quality assurance and regulatory adherence, and the emergence of biosimilars production.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10181&type=smp

Which Drivers Are Impacting The Biopharmaceuticals Contract Manufacturing Market?

The expanding need for personalized medicine is projected to fuel the advancement of the biopharmaceutical contract manufacturing market in the future. Personalized medicine signifies a tailored healthcare strategy considering unique patient attributes like genetics, environment, and lifestyle to improve treatment efficacy and results. This rising demand for personalized medicine stems from multiple elements, such as progress in genomics, greater patient involvement, and enhanced treatment effectiveness. Contract manufacturers possess the capability to develop customized production methods crafted to meet the precise demands of personalized treatments, allowing for small batch production and distinct formulations. As an illustration, data from February 2024, reported by the Personalized Medicine Coalition, a US-based non-profit organization, indicates that the FDA gave approval to 16 novel personalized therapies for individuals with rare diseases in 2023, which is an increase from six approvals in 2022. Consequently, the increasing call for personalized medicine significantly boosts the expansion of the biopharmaceutical contract manufacturing market.

What Are The Emerging Segments Gaining Attention In The Biopharmaceuticals Contract Manufacturing Market?

The biopharmaceuticals contract manufacturing market covered in this report is segmented –

1) By Product: Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, And Molecular Therapy, Biosimilars

2) By Source: Mammalian, Non-mammalian

3) By Service: Process Development, Fill And Finish Operations, Analytical And QC studies, Packaging

4) By Application: Clinical, Commercial

Subsegments:

1) By Biologics: Enzymes, Hormones, Antibodies

2) By Monoclonal Antibodies (MABs): Human MABs, Chimeric MABs, Murine MABs

3) By Recombinant Proteins: Insulin, Growth Factors, Cytokines

4) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines

5) By Antisense, RNAi, And Molecular Therapy: Antisense Oligonucleotides, RNA Interference Products, Gene Therapies

6) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Insulin, Biosimilar Growth Hormones

How Are Emerging Market Trends Shaping The Biopharmaceuticals Contract Manufacturing Industry Landscape?

Product innovations represent a significant trend increasing in popularity within the biopharmaceuticals contract manufacturing market. Major companies active in the biopharmaceutical contract manufacturing market are developing advanced products to sustain their market position. For instance, in February 2023, Thermo Fisher Scientific, a US-based biotechnology research company, and Elektrofi, a US-based biotechnology company specializing in drug formulation and delivery innovations, finalized a strategic contract manufacturing agreement to support the commercial production of Elektrofi’s pioneering ultra-high concentration subcutaneous products. Elektrofi’s unique microparticle technology facilitates small-volume injections of biologics such as monoclonal antibodies, therapeutic proteins, and other large-molecule medications vital for human health. Additionally, Elektrofi’s platform technology enables patients to self-administer medicines at home rather than in a hospital setting, effectively overcoming the difficulties associated with giving biologic-based medications.

Who Are The Major Companies Operating In The Biopharmaceuticals Contract Manufacturing Market?

Major companies operating in the biopharmaceuticals contract manufacturing market include Boehringer Ingelheim GmbH, Lonza Group Ltd., Inno Biologics Sdn Bhd, Rentschler Biopharma SE, Samsung Biologics Co. Ltd., AGC Biologics, ProBioGen AG, FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific Inc., Binex Co. Ltd., AbbVie Inc., Catalent Inc, Pfizer Inc., Merck KGaA, Pressure BioSciences, Novartis International AG, Cambrex Corporation, Emergent BioSolutions Inc., JRS Pharma GmbH & Co. KG, WuXi Biologics, Siegfried Holding AG, Toyobo Co. Ltd., ADMA Biologics Inc., UCB S.A., AstraZeneca PLC, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Shire Pharmaceuticals LLC, Baxter International Inc., Becton Dickinson and Company, Polyphor Ltd., Patheon Inc., Alcami Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/biopharmaceuticals-contract-manufacturing-global-market-report

Which Regional Markets Are Contributing Most To The Biopharmaceuticals Contract Manufacturing Industry Expansion?

North America was the largest region in the biopharmaceutical contract manufacturing market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global biopharmaceuticals contract manufacturing market forecast period. The regions covered in the biopharmaceuticals contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Biopharmaceuticals Contract Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10181&type=smp

Browse Through More Reports Similar to the Global Biopharmaceuticals Contract Manufacturing Market 2025, By The Business Research Company

Medical Radiation Detection Monitoring And Safety Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-radiation-detection-monitoring-and-safety-global-market-report

Medical Aesthetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-aesthetics-global-market-report

Manufacturing Analytics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/manufacturing-analytics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795